Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1455768

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1455768

Global Emulsified Vitamin D3 Market - 2023-2030

PUBLISHED:
PAGES: 225 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Overview

Global Emulsified Vitamin D3 Market reached US$ 588.11 million in 2022 and is expected to reach US$ 895.74 million by 2030, growing with a CAGR of 5.4% during the forecast period 2023-2030.

Modern lifestyles often involve spending less time outdoors for work, leisure or sun protection, limiting natural vitamin D production in the skin, a primary source for most people. Vitamin D3 is an important vitamin needed for bone health osteoporosis and rickets aversion. It has various roles and is used in the food, feed and healthcare industries. The global prevalence of chronic diseases like osteoporosis, autoimmune disorders, and certain cancers is on the rise.

Vitamin D sufficiency is linked to a reduced risk of developing some of the various conditions, propelling the market for emulsified vitamin D3. Emulsified vitamin D3 comes in various forms like liquid drops and chewable tablets, making them easy to consume for different age groups and preferences. Factors like rising awareness of vitamin D deficiency, increasing disposable income, and growing adoption of new healthcare technologies contribute to market expansion globally.

North America dominated the global emulsified vitamin D3 market. According to Bone Health & Osteoporosis Foundation August 2021, approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone and should be concerned about bone health. The high demand for vitamin D to deal with various deficiency disorders is driving market growth.

Dynamics

Increasing Vitamin Deficiency Worldwide

According to the National Institutes of Health, in July 2023, about 1 billion people worldwide had vitamin D deficiency, while 50% of the population had vitamin D insufficiency. With growing awareness of vitamin D deficiency, there is a greater need for supplementation for vitamin deficiency to maintain good health conditions, increasing the supplementation for vitamin D3.

According to the National Health and Nutrition Examination Survey conducted from 2017 to March 2020, around 3% of young people and 18.5% of adults reported using vitamin D supplements. Of those who reported using vitamin D supplements, 33.9% of young people and 66.9% of adults took the supplement every day for 30 days. The higher the need for supplementation to deal with vitamin deficiencies, there is also greater demand for the emulsified vitamin D3 due to its effective nature.

Benefits of Emulsified Vitamin D3

Emulsified vitamin D3 supplements provide a simple and effective way to increase vitamin D intake, regardless of sun exposure or dietary limitations, increasing the supplementation habits in daily life. With growing awareness of vitamin D deficiency, emulsified D3 is targeting a wider age range, from young adults to seniors concerned about bone health. Vitamin D is linked to various health benefits, and emulsified options cater to this focus on preventative measures with their improved absorption and convenience.

The emulsification process breaks down vitamin D3 into smaller particles, allowing for better absorption in the gut compared to traditional tablets or capsules. This is especially beneficial for individuals with digestive issues or those who may not absorb nutrients effectively. Emulsified vitamin D3 comes in various forms like liquid drops and gummies, making it easier to consume for children, elderly individuals, or those who have trouble swallowing pills.

High-Cost of Emulsified Vitamin D3

Traditional vitamin D3 supplements are relatively simple to manufacture. They involve mixing dry ingredients and compressing them into tablets or capsules. Emulsified options require additional steps. The vitamin D3 needs to be dispersed into a liquid carrier using special emulsifying agents. This process is more complex and requires specialised equipment, contributing to higher production costs.

Emulsified formulas often use additional ingredients like oils and emulsifiers to create a stable emulsion. These additional ingredients can add to the overall cost compared to the simpler ingredients used in traditional supplements. The production process and ingredients of the emulsified vitamin D3 make them costlier compared to traditional vitamin D3. Price-sensitive customers choose low-priced products hindering the market growth.

Segment Analysis

The global emulsified vitamin D3 market is segmented based on dosage, form, flavor, target audience, distribution channel, application and region.

High Vitamin D Deficiency Among Adult Population

The global emulsified vitamin D3 market is segmented based on target audience into infants and children, pregnant and lactating women and adults. Each target audience benefits from the emulsified vitamin D3 in a similar manner, but the need and use of vitamin D3 among adults is higher compared to other age groups driving the segment growth. According to the August 2022, American Academy of Pediatrics 32% of young adults were deficient in vitamin D.

In the adult population, 35% of adults in United States are vitamin D deficient whereas over 80% of adults in Pakistan, India, and Bangladesh are vitamin D deficient. Similarly, 61% of the elderly population is vitamin D deficient in United States, whereas 90% in Turkey, 96% in India, 72% in Pakistan, and 67% in Iran were vitamin D deficient. To deal with the increasing deficiencies among the age groups, there is a higher demand for emulsified vitamin D3 for an efficient vitamin supply into the body.

Geographical Penetration

High Prevalence of Vitamin Deficiency in North America

North America dominated the global emulsified vitamin D3 market. Regional countries such as United States and Canada have a high prevalence of vitamin D deficiency. In the United States, 47% of African American infants and 56% of Caucasian infants have vitamin D deficiency. About 50% to 60% of nursing home residents and hospitalized patients have vitamin D deficiency in U.S.

Public health campaigns and media attention have raised awareness of this issue, leading to increased interest in vitamin D supplementation. People in North America are increasingly interested in preventive healthcare and taking a proactive approach to managing their health. The North American market is often receptive to new technologies and products. Emulsified Vitamin D3 is a relatively innovation, and North American companies are quicker to adopt and manufacture it compared to other regions.

Competitive Landscape

The major global players in the market include BASF, Biotics Research Corporation, Adaptogen Research, Body of Harmony, bodykind Ltd., Naka Pro, Nutri-Link, gnanaturals, Nutra Biogenesis and Designs for Health, Inc.

COVID-19 Impact Analysis

The COVID-19 pandemic had both positive and negative impact on the global market. The pandemic caused disruptions in global supply chains for raw materials and manufacturing processes. This led to temporary shortages or price fluctuations for emulsified Vitamin D3 supplements. The economic impact of COVID-19 has led some consumers to cut back on discretionary spending, potentially affecting sales of non-essential items like vitamin supplements.

The pandemic highlighted the importance of a strong immune system. Research studies suggesting a potential link between vitamin D sufficiency and reduced risk of respiratory infections have boosted interest in vitamin D supplementation. This has likely driven demand for emulsified vitamin D3 due to its potentially better absorption. A surge in e-commerce for various products, including health supplements, had a positive impact on the market as well.

By Dosage

  • Low Dose (400 IU)
  • Medium Dose (1,000 IU)
  • High Dose (2,000 IU or more)

By Form

  • Softgels
  • Liquids (Drops)
  • Chewable Tablets

By Flavor

  • Raspberry
  • Lemon
  • Orange
  • Others

By Target Audience

  • Infants and Children
  • Pregnant and Lactating Women
  • Adults

By Distribution Channel

  • Pharmacies and Drugstores
  • Specialty Stores
  • E-Commerce
  • Others

By Application

  • Food
  • Feed
  • Healthcare

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In February 2024, Cadila Pharmaceuticals, an Indian pharmaceutical company announced the launch of the first-ever aqueous injection of vitamin D.
  • In February 2022, Amway launched a range of nutrition supplements. Nutrilite D-Fence Vitamin D3 Jelly Strip are in trendy, tasty, convenient and simplified formats.
  • In February 2021, DSM announced the approval of a new Certificate of Suitability for a vitamin D3 powder form.

Why Purchase the Report?

  • To visualize the global emulsified vitamin D3 market segmentation based on dosage, form, flavor, target audience, distribution channel, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of emulsified vitamin D3 market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global emulsified vitamin D3 market report would provide approximately 86 tables, 84 figures and 225 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB8229

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Dosage
  • 3.2.Snippet by Form
  • 3.3.Snippet by Flavor
  • 3.4.Snippet by Target Audience
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Application
  • 3.7.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.High Need to Deal with the Increasing Vitamin Deficiency Worldwide
      • 4.1.1.2.Benefits of Emulsified Vitamin D3
    • 4.1.2.Restraints
      • 4.1.2.1.High-Cost of Emulsified Vitamin D3
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Dosage

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 7.1.2.Market Attractiveness Index, By Dosage
  • 7.2.Low Dose (400 IU)
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Volume-Based Systems
  • 7.4.Medium Dose (1,000 IU)
  • 7.5.High Dose (2,000 IU or more)

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Softgels
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Liquids (Drops)
  • 8.4.Chewable Tablets

9.By Flavor

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 9.1.2.Market Attractiveness Index, By Flavor
  • 9.2.Raspberry
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Lemon
  • 9.4.Orange
  • 9.5.Others

10.By Target Audience

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 10.1.2.Market Attractiveness Index, By Target Audience
  • 10.2.Infants and Children
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Pregnant and Lactating Women
  • 10.4.Adults

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Pharmacies and Drugstores
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Non-agricultural
  • 11.4.Specialty Stores
  • 11.5.E-Commerce
  • 11.6.Others

12.By Application

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2.Market Attractiveness Index, By Application
  • 12.2.Food
    • 12.2.1.Introduction
    • 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3.Feed
  • 12.4.Healthcare

13.By Region

  • 13.1.Introduction
    • 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2.Market Attractiveness Index, By Region
  • 13.2.North America
    • 13.2.1.Introduction
    • 13.2.2.Key Region-Specific Dynamics
    • 13.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.9.1.U.S.
      • 13.2.9.2.Canada
      • 13.2.9.3.Mexico
  • 13.3.Europe
    • 13.3.1.Introduction
    • 13.3.2.Key Region-Specific Dynamics
    • 13.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.9.1.Germany
      • 13.3.9.2.U.K.
      • 13.3.9.3.France
      • 13.3.9.4.Italy
      • 13.3.9.5.Spain
      • 13.3.9.6.Rest of Europe
  • 13.4.South America
    • 13.4.1.Introduction
    • 13.4.2.Key Region-Specific Dynamics
    • 13.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.9.1.Brazil
      • 13.4.9.2.Argentina
      • 13.4.9.3.Rest of South America
  • 13.5.Asia-Pacific
    • 13.5.1.Introduction
    • 13.5.2.Key Region-Specific Dynamics
    • 13.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.9.1.China
      • 13.5.9.2.India
      • 13.5.9.3.Japan
      • 13.5.9.4.Australia
      • 13.5.9.5.Rest of Asia-Pacific
  • 13.6.Middle East and Africa
    • 13.6.1.Introduction
    • 13.6.2.Key Region-Specific Dynamics
    • 13.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

14.Competitive Landscape

  • 14.1.Competitive Scenario
  • 14.2.Market Positioning/Share Analysis
  • 14.3.Mergers and Acquisitions Analysis

15.Company Profiles

  • 15.1.BASF
    • 15.1.1.Company Overview
    • 15.1.2.Product Portfolio and Description
    • 15.1.3.Financial Overview
    • 15.1.4.Key Developments
  • 15.2.Biotics Research Corporation
  • 15.3.Adaptogen Research
  • 15.4.Body of Harmony
  • 15.5.bodykind Ltd.
  • 15.6.Naka Pro
  • 15.7.Nutri-Link
  • 15.8.gnanaturals
  • 15.9.Nutra Biogenesis
  • 15.10.Designs for Health, Inc.

LIST NOT EXHAUSTIVE

16.Appendix

  • 16.1.About Us and Services
  • 16.2.Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!